Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica R Gadelha

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Pituitary|June 14, 2023
Refractory somatotroph adenomasMonica R Gadelha, Leandro Kasuki
Presse Medicale (Paris, France : 1983)|October 23, 2021
ProlactinomasLuiz Eduardo Wildemberg, Christhiane Fialho, Monica R Gadelha
The Journal of Clinical Endocrinology and Metabolism|October 7, 2021
The Future of Somatostatin Receptor Ligands in AcromegalyMonica R Gadelha, Luiz Eduardo Wildemberg, Leandro Kasuki
Hormones (Athens, Greece)|May 14, 2017
Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical controlIlan Shimon, Wolfgang Saeger, Luiz Eduardo Wildemberg, et al.
Endocrine Connections|August 2, 2023
Long-term, real-world experience of pasireotide dose reduction in patients with acromegalyNelma Verônica Marques, Luiz Eduardo Armondi Wildemberg, Monica R Gadelha
Frontiers of Hormone Research|May 9, 2013
Genetics of pituitary adenomasMonica R Gadelha, Giampaolo Trivellin, Laura Cristina Hernández Ramírez, et al.
Pituitary|February 9, 2017
Somatostatin receptor ligands in the treatment of acromegalyMonica R Gadelha, Luiz Eduardo Wildemberg, Marcello D Bronstein, et al.
International Journal of Molecular Sciences|August 12, 2022
MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor LigandsDaniel G Henriques, Elisa B Lamback, Romulo S Dezonne, et al.
Endocrine|May 27, 2021
GH and IGF-I levels and tumor shrinkage in response to first generation somatostatin receptor ligands in acromegaly: a comparative study between two reference centers for pituitary diseases in BrazilKarina Zanlorenzi Basso Manosso, Carolina Labigalini Sampaio, Leandro Kasuki, et al.
Pituitary|April 2, 2009
Hematologic neoplasias and acromegalyFlavia Regina P Barbosa, Leonardo Vieira Neto, Giovanna Aparecida B Lima, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Pituitary|June 14, 2023
Refractory somatotroph adenomasMonica R Gadelha, Leandro Kasuki
Presse Medicale (Paris, France : 1983)|October 23, 2021
ProlactinomasLuiz Eduardo Wildemberg, Christhiane Fialho, Monica R Gadelha
The Journal of Clinical Endocrinology and Metabolism|October 7, 2021
The Future of Somatostatin Receptor Ligands in AcromegalyMonica R Gadelha, Luiz Eduardo Wildemberg, Leandro Kasuki
Hormones (Athens, Greece)|May 14, 2017
Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical controlIlan Shimon, Wolfgang Saeger, Luiz Eduardo Wildemberg, et al.
Endocrine Connections|August 2, 2023
Long-term, real-world experience of pasireotide dose reduction in patients with acromegalyNelma Verônica Marques, Luiz Eduardo Armondi Wildemberg, Monica R Gadelha
Frontiers of Hormone Research|May 9, 2013
Genetics of pituitary adenomasMonica R Gadelha, Giampaolo Trivellin, Laura Cristina Hernández Ramírez, et al.
Pituitary|February 9, 2017
Somatostatin receptor ligands in the treatment of acromegalyMonica R Gadelha, Luiz Eduardo Wildemberg, Marcello D Bronstein, et al.
International Journal of Molecular Sciences|August 12, 2022
MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor LigandsDaniel G Henriques, Elisa B Lamback, Romulo S Dezonne, et al.
Endocrine|May 27, 2021
GH and IGF-I levels and tumor shrinkage in response to first generation somatostatin receptor ligands in acromegaly: a comparative study between two reference centers for pituitary diseases in BrazilKarina Zanlorenzi Basso Manosso, Carolina Labigalini Sampaio, Leandro Kasuki, et al.
Pituitary|April 2, 2009
Hematologic neoplasias and acromegalyFlavia Regina P Barbosa, Leonardo Vieira Neto, Giovanna Aparecida B Lima, et al.
Pageof 4